Connecting oncology professionals with relevant clinical trials

Selected clinical trial

THERANOVA (NMN-02/MEDOPP838): Adaptive Diagnostic and Therapeutic Radioligand Platform for Solid Tumors With Active Brain Metastases

Sponsor: Medica Scientia Innovation Research S.L.

Phase:

Disease: Brain metastases from solid tumors, Advanced solid tumors

EU trial number: 2025-523824-39-01

Population: Patients with active brain metastases originating from solid tumors, enrolled into distinct diagnostic or therapeutic agent-specific subcohorts according to target expression and module criteria.

Register Investigator Interest

Interested in offering this trial to suitable patients?